Breaking News Instant updates and real-time market news.

ORCL

Oracle

$50.27

0.68 (1.37%)

, PANW

Palo Alto Networks

$154.23

2.63 (1.73%)

07:01
01/18/18
01/18
07:01
01/18/18
07:01

Jefferies sees more upside in Software stocks despite 'rich' valuations

Despite "rich" valuations, Software stocks have room for appreciation, Jefferies analyst John DiFucci tells investors in a research note. The analyst says "secular forces" are as positive as he's seen in nearly two decades of covering Software due to advances in foundational computing tech, while cyclical forces "are also on the upswing." Lower corporate tax rates will benefit some in the sector while repatriation may benefit all, DiFucci contends. The analyst's top picks for 2018 are Oracle (ORCL), Palo Alto Networks (PANW) and Apptio (APTI). He upgraded this morning Alarm.com (ALRM) and Nice (NICE) to Buy from Hold while downgrading Symantec (SYMC) to Underperform from Hold. The analyst also raised his price target for Buy-rated RingCentral (RNG) to $60 from $52, Buy-rated Splunk (SPLK) to $105 from $88 and Buy-rated VMware (VMW) to $165 from $140.

ORCL

Oracle

$50.27

0.68 (1.37%)

PANW

Palo Alto Networks

$154.23

2.63 (1.73%)

APTI

Apptio

$24.00

0.29 (1.22%)

ALRM

Alarm.com

$38.27

1.26 (3.40%)

NICE

Nice

$92.63

0.67 (0.73%)

SYMC

Symantec

$27.52

-0.35 (-1.26%)

RNG

RingCentral

$51.50

0.85 (1.68%)

SPLK

Splunk

$90.57

3.44 (3.95%)

VMW

VMware

$135.33

3.19 (2.41%)

  • 18

    Jan

  • 31

    Jan

  • 05

    Feb

  • 26

    Feb

  • 27

    Feb

ORCL Oracle
$50.27

0.68 (1.37%)

01/03/18
MSCO
01/03/18
UPGRADE
MSCO
Overweight
Oracle upgraded to Overweight from Equal Weight at Morgan Stanley
01/03/18
01/03/18
UPGRADE
Target $57

Overweight
Morgan Stanley gives five reasons to go long Oracle
As previously reported, Morgan Stanley analyst Keith Weiss upgraded Oracle to Overweight from Equal Weight, arguing that its current low valuation with cloud expectations diminished following its last three earnings reports presents "a tactical opportunity for old fashioned earnings growth to drive the shares higher." As five reasons to be long, Weiss points to: the database cycle being in "full swing"; expectations being reset for its SaaS applications; the fact that Oracle's effective tax rate is likely coming down; the positive impact of repatriation; and its current valuation looks inexpensive compared to the stock's historical ranges. Weiss raised his price target on Oracle shares to $57 from $50.
01/03/18
01/03/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Mills (GIS) upgraded to Neutral from Underweight at Piper Jaffray with analyst Michael Lavery saying he expects the company to use some of its tax reform benefit to increase "needed" brand investments. He sees the company posting 9%-10% average earnings growth over the next six quarters. 2. Ulta Beauty (ULTA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying he sees "compelling setup" for the shares in 2018 given the company's "material" tax benefit and potential for fundamental stabilization. 3. IBM (IBM) upgraded to Outperform from Sector Perform at RBC Capital with analyst Amit Daryanani citing the benefits of the mainframe cycle upgrade, a favorable FX backdrop for the first time in 3 years, recovery in hybrid IT spending leading to 1%-3% revenue growth, and attractive 11-times PE valuation. 4. Oracle (ORCL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Keith Weiss arguing that its current low valuation with cloud expectations diminished following its last three earnings reports presents "a tactical opportunity for old fashioned earnings growth to drive the shares higher." 5. United Technologies (UTX) upgraded to Outperform from Sector Perform at RBC Capital analyst Deane Dray saying 2018 will mark the final year of margin pressure at the company's Pratt and Otis units which led to the recent underperformance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/02/18
DRXL
01/02/18
NO CHANGE
Target $62
DRXL
Buy
Drexel Hamilton says buy Oracle dip as Information report seems like 'fake news'
Drexel Hamilton analyst Brian White believes that The Information's report claiming that Salesforce (CRM) and Amazon (AMZN) are moving away from using Oracle (ORCL) databases is inaccurate, he tells investors in a note entitled "AMZN and CRM to Dump Oracle? - Sounds Like Fake News to Us." The analyst, who said he would be a buyer of Oracle on weakness driven by the report, noted that there have been similar stories about Salesforce in the past that turned out to be false, as he believes is the case again here. He maintains a Buy rating and $62 price target on Oracle shares.
PANW Palo Alto Networks
$154.23

2.63 (1.73%)

11/21/17
11/21/17
UPGRADE
Target $175

Outperform
Palo Alto Networks upgraded to Outperform at FBN Securities
As previously reported, FBN Securities analyst Shebly Seyrafi upgraded Palo Alto Networks to Outperform from Sector Perform as the company reported a "strong" Q1 and his checks indicate a "strong" Q2. The analyst also raised his price target on the shares to $175 from $155, while noting that Palo Alto Networks continues to be a share gainer in security.
01/05/18
NORL
01/05/18
NO CHANGE
Target $175
NORL
Outperform
Palo Alto Networks named a 2018 top pick at Northland
Northland analyst Robert Breza named Palo Alto Networks (PANW) a 2018 top pick, noting that the company is now the largest firewall vendor with a comprehensive security platform that includes endpoint protection. He also pointed out that its revenue growth is "significantly faster" than peers Check Point (CHKP) and Fortinet (FTNT) while its valuation is attractive given the discount to the group. Breza has an Outperform rating and $175 price target on Palo Alto shares.
12/04/17
WBLR
12/04/17
UPGRADE
WBLR
Outperform
Palo Alto Networks upgraded to Outperform from Market Perform at William Blair
William Blair analyst Jonathan Ho upgraded Palo Alto Networks to Outperform saying the company's application framework is likely to widen the "competitive gap" relative to peers.
11/21/17
FBNS
11/21/17
UPGRADE
FBNS
Outperform
Palo Alto Networks upgraded to Outperform from Sector Perform at FBN Securities
APTI Apptio
$24.00

0.29 (1.22%)

07/12/17
KEYB
07/12/17
NO CHANGE
KEYB
Apptio should be bought ahead of results, says KeyBanc
KeyBanc analyst Ben McFadden says that Apptio's sales to new customers are "gaining momentum," while it is making progress in selling additional products to existing customers. He recommends buying the stock ahead of the company's results.
11/27/17
JMPS
11/27/17
INITIATION
Target $28
JMPS
Outperform
Apptio initiated with an Outperform at JMP Securities
JMP Securities analyst Greg McDowell started Apptio with an Outperform rating and $28 price target, saying he views it as a market leader in the technology business management solutions arket, which he sees as both underpenetrated and underappreciated.
07/28/17
07/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Apptio (APTI) initiated with an Outperform at Oppenheimer. 2. ShotSpotter (SSTI) initiated with an Outperform at Imperial Capital. 3. Pitney Bowes (PBI) initiated with a Hold at Loop Capital. 4. PayPal (PYPL) assumed with an Overweight at Cantor. 5. Columbus McKinnon (CMCO) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/27/17
OPCO
07/27/17
INITIATION
Target $25
OPCO
Outperform
Apptio initiated with an Outperform at Oppenheimer
Oppenheimer analyst Brian Schwartz initiated Apptio with an Outperform and a $25 price target saying its a leading SaaS vendor with strong growth and improving margins. The analyst believes shares will move higher as the company becomes larger and increasingly profitable by capturing more IT spending by extending its best-of-breed platform products across a growing installed base.
ALRM Alarm.com
$38.27

1.26 (3.40%)

11/09/17
IMPC
11/09/17
NO CHANGE
IMPC
Alarm.com weakness may be buying opportunity, says Imperial Capital
Imperial Capital analyst Jeff Kessler noted that Alarm.com's third quarter results were above Imperial's estimates on both the top and bottom lines, and believes the company is "strategically positioned to penetrate the DIY home automation market and provide enhanced monitoring services" going forward. Kessler has an In-Line rating and $45 price target on Alarm.com shares.
11/09/17
FBCO
11/09/17
NO CHANGE
Target $52
FBCO
Outperform
Alarm.com price target raised to $52 from $46 at Credit Suisse
Credit Suisse analyst Michael Nemeroff raised his price target for Alarm.com to $52 from $46 after the company delivered another "strong" quarter, with revenue, EPS, and cash flows all above consensus. The analyst reiterates an Outperform rating on the shares.
10/25/17
RAJA
10/25/17
NO CHANGE
RAJA
Amazon Key perceived as negative for Netgear, says Raymond James
Raymond James analyst Simon Leopold says the announcement of Amazon Key (AMZN) is likely to be perceived by the market as a negative for Netgear (NTGR). It is unclear, however, if Amazon's goal with Key is to open up camera options to include retail products as well various alarm monitoring providers, Leopold tells investors in a research note. Shares of Netgear, which is reporting results tonight, are down 4% to $48.40 in midday trading. Also lower following Amazon's announcement is Alarm.com (ALRM) and Allegion (ALLE).
01/18/18
JEFF
01/18/18
UPGRADE
Target $46
JEFF
Buy
Alarm.com upgraded to Buy from Hold at Jefferies
Jefferies analyst John DiFucci upgraded Alarm.com to Buy and raised his price target for the shares to $46 from $44. Alarm.com is at the forefront of the trend towards connected homes and devices, DiFucci tells investors in a research note. The analyst believes the company has a large international opportunity and finds the valuation attractive at current levels. He notes Alarm.com will benefit from lower corporate taxes.
NICE Nice
$92.63

0.67 (0.73%)

11/03/17
JPMS
11/03/17
DOWNGRADE
Target $90
JPMS
Neutral
Nice downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Paul Coster downgraded Nice to Neutral with an unchanged price target of $90. The analyst sees a lack of near-term catalysts and believes the shares are for a period of consolidation "during what is typically the quietest season for the company." He notes the stock is up 22% year-to-date.
11/06/17
CHDN
11/06/17
DOWNGRADE
CHDN
Neutral
Nice downgraded to Neutral from Buy at Chardan
Chardan analyst Lena Rogovin downgraded Nice to Neutral citing valuation and raised its price target to $91.
12/13/17
OPCO
12/13/17
NO CHANGE
Target $100
OPCO
Outperform
Nice price target raised to $100 from $90 at Oppenheimer
Oppenheimer analyst Shaul Eyal raised his price target for Nice to $100 from $90, citing "solid" demand and continued innovation that support higher valuation. The analyst reiterates an Outperform rating on the shares.
01/18/18
JEFF
01/18/18
UPGRADE
Target $112
JEFF
Buy
Nice upgraded to Buy from Hold at Jefferies
Jefferies analyst John DiFucci upgraded Nice to Buy and raised his price target for the shares to $112 from $87. The company's revenue growth has the potential to accelerate due to strong cloud sales, accelerated new business, and "robust" initial uptake of CXone, DiFucci tells investors in a research note. He believes the valuation is still attractive despite the recent share rally.
SYMC Symantec
$27.52

-0.35 (-1.26%)

12/19/17
DBAB
12/19/17
INITIATION
Target $30
DBAB
Hold
Symantec initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Karl Keirstead started Symantec with a Hold rating and $30 price target. The analyst has some concerns about the second half of 2018 and fiscal 2019 revenue trajectory of the company's Enterprise segment. He's not convinced that the Blue Coat refresh will play out as planned.
11/02/17
LEHM
11/02/17
NO CHANGE
Target $36
LEHM
Overweight
Symantec revenue outlook in-line with expectations, says Barclays
Barclays analyst Saket Kalia says that despite the moving parts, Symantec's fiscal 2018 revenue is in-line with core expectations. The analyst believes the takeaways from the quarter, "when the dust settles," is that the outlook is largely unchanged, with slightly higher consumer and slightly lower enterprise, results would have beat when adding back $25M in additional deferrals in Enterprise, and that the year is slightly more back-end loaded. Kalia keeps an Overweight rating on Symantec shares with a $36 price target.
01/18/18
JEFF
01/18/18
DOWNGRADE
Target $23
JEFF
Underperform
Symantec downgraded to Underperform from Hold at Jefferies
Jefferies analyst John DiFucci downgraded Symantec to Underperform and cut his price target for the shares to $23 from $30. The company's current guidance is unachievable and the stock will rerate lower upon investor realization, DiFucci tells investors in a research note. The analyst says near double-digit growth is implied for the upcoming Q4 results and mid-to-high single digit growth thereafter. He thinks expectations will need to be lowered.
10/10/17
10/10/17
DOWNGRADE
Target $34

Equal Weight
Symantec downgraded to Equal Weight after rally at Morgan Stanley
As previously reported, Morgan Stanley analyst Keith Weiss downgraded Symantec to Equal Weight from Overweight, noting his field work has remained relatively stable, suggesting that the company's improved product positioning has yet to translate into accelerating demand, though the stock has risen over 35% year-to-date. As he now views the risk/reward skewing more balanced, he lowered his rating and cut his price target on Symantec shares to $34 from $37.
RNG RingCentral
$51.50

0.85 (1.68%)

12/12/17
JPMS
12/12/17
DOWNGRADE
Target $52
JPMS
Neutral
RingCentral downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Sterling Auty downgraded RingCentral to Neutral with an unchanged price target of $52 in conjunction with his 2018 annual outlook for Software Technology. The analyst does not expect the "exceptional performance" in Software during 2017 to repeat in 2018. As such, he's moderating his bullish outlook into next year.
12/06/17
OPCO
12/06/17
NO CHANGE
Target $56
OPCO
Outperform
RingCentral price target raised to $56 from $50 at Oppenheimer
Oppenheimer analyst Brian Schwartz raised his price target for RingCentral to $56 from $50 saying its business appears set to close 2017 with strong momentum. The analyst reiterates an Outperform rating on the shares.
12/13/17
RHCO
12/13/17
NO CHANGE
Target $50
RHCO
Buy
RingCentral investor meeting supports revenue growth forecast, says SunTrust
SunTrust analyst Terry Tillman says he is "as confident as ever" that RingCentral will maintain a "solid-to-strong revenue growth and consistent improvement in operating margins and cash flow" after investor meetings with the management. Tillman keeps his Buy rating and $50 price target, adding that the company's international opportunities represent notable upside drivers for 2018 and 2019, while also citing progress for RingCentral in building out its channel partnerships as a "growing source of new bookings".
01/17/18
01/17/18
UPGRADE
Target $19

Overweight
8x8, Inc. upgraded to Overweight on UCaaS share gains at Morgan Stanley
As previously reported, Morgan Stanley analyst Meta Marshall upgraded 8x8, Inc. (EGHT) to Overweight from Equal Weight, as he believes the market appears to be missing that the company should be a share gainer in the Unified Communications as a Service, or UCaaS market, which is estimated to be growing at a 15% rate. While Marshall noted that he is not calling for 8x8 to grow as fast as RingCentral's (RNG) 25%-30% rate, he thinks there likely will be multiple winners and 8x8 can grow faster than the market. He raised his price target on 8x8 shares to $19 from $17.
SPLK Splunk
$90.57

3.44 (3.95%)

01/12/18
DBAB
01/12/18
NO CHANGE
Target $100
DBAB
Buy
Splunk price target raised to $100 from $85 at Deutsche Bank
Deutsche Bank analyst Karl Keirstead raised his price target for Splunk to $100 saying channel checks on the company's January quarter have been bullish. The analyst picked up evidence from several large customers and partners of a demand uptick, especially regarding the use of Splunk for security-related use cases. Checks reaffirm that the company's demand and execution are improving, Keirstead tells investors in a research note. He keeps a Buy rating on Splunk shares.
01/08/18
LEHM
01/08/18
UPGRADE
Target $105
LEHM
Overweight
Splunk upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Raimo Lenschow upgraded Splunk to Overweight and raised his price target for the shares to $105 from $80. The analyst sees the Security Event Management replacement cycle as a potential catalyst for positive estimate revisions.
12/18/17
BARD
12/18/17
NO CHANGE
Target $90
BARD
Outperform
Splunk price target raised to $90 from $85 at Baird
Baird analyst Rob Oliver raised his price target on Splunk to $90 from $85 citing a meaningful spike in job openings tracked by the firm, activity with the December year-end Federal security sending deadline, its competitive advantages, and modestly easier comps that are upcoming. Oliver reiterated his Outperform rating on Splunk shares.
11/27/17
SBSH
11/27/17
NO CHANGE
Target $73
SBSH
Neutral
Splunk outlook well below consensus without ASC 606 impact, says Citi
Citi analyst Walter Pritchard believes Splunk's fiscal 2019 revenue guidance excluding the Accounting Standards Codification 606 impact is well below the consensus. Citing his estimates and management's commentary at analyst day, Pritchard sees the impact on revenue from the accounting change at $100M-plus and the corresponding impact on operating margin at 200 basis points, which he notes is the entire year-over-year margin expansion currently included in the guidance. Splunk shares rallied "substantially more than deserved" on the Q3 earnings report because of perceived strength in the guidance, Pritchard told investors earlier in a research note. The analyst believes more than all the "better" fiscal 2019 guidance is due to ASC 606. He keeps a Neutral rating on Splunk with a $73 price target. The stock in early trading is down 2c to $84.08.
VMW VMware
$135.33

3.19 (2.41%)

01/11/18
COWN
01/11/18
UPGRADE
COWN
Outperform
VMware upgraded to Outperform from Market Perform at Cowen
01/11/18
01/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Expedia (EXPE) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Brian Nowak saying he remains bullish on the company's room night supply and HomeAway ability driving faster long-term Room Night Growth, also adding that Expedia has a history of offering conservative guidance. 2. STMicroelectronics (STM) upgraded to Outperform from Neutral at Credit Suisse with analyst Achal Sultania saying that Apple (AAPL) front-end 3D opportunity can add another $450M-$500M of incremental sales over the next 2 years and expects EBIT contribution from advanced imaging business to improve. 3. American Eagle (AEO) upgraded to Buy from Neutral at Buckingham with analyst Kelly Halsor expecting solid momentum to be driven by strong demand for fashion apparel, particularly denim, continued upside at Aeeri, a gross margin inflection in the first half 2018 driven by merchandising margin improvement, and tax reform benefits. 4. VMware (VMW) upgraded to Outperform from Market Perform at Cowen with analyst Gregg Moskowitz saying strong data from his IT survey and recent channel checks increase his confidence in the company's ability to execute at a high level. 5. Zillow (Z, ZG) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Jonathan Lanterman noting that the stock's valuation has fallen to 2-year lows after underperforming in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/18
RBCM
01/17/18
NO CHANGE
Target $150
RBCM
Outperform
VMware price target raised to $150 from $137 at RBC Capital
RBC Capital analyst Matt Hedberg raised his price target on VMWare to $150 and kept his Outperform rating, saying he "feels better" about his positive view on the company's hybrid and cross-cloud drivers. Hedberg contends that VMWare is an "under-owned name in large-cap software with several drivers and a reasonable free cash flow valuation". He continues to have a positive view on the benefits from "Act 1 of compute virtualization" and "Act 2 of network virtualization".
01/11/18
COWN
01/11/18
UPGRADE
Target $150
COWN
Outperform
VMware upgraded to Outperform at Cowen
As reported previously, Cowen analyst Gregg Moskowitz upgraded VMware (VMW) to Outperform from Market Perform. The analyst said strong data from his IT survey and recent channel checks increase his confidence in the company's ability to execute at a high level. He also noted strong demand for vSphere and strong interest in the joint AWS (AMZN) offering. Moskowitz raised his price target to $150 from $130 on VMware shares.

TODAY'S FREE FLY STORIES

DEL

Deltic Timber

$98.45

1.77 (1.83%)

, PCH

Potlatch

$54.75

0.75 (1.39%)

14:45
02/17/18
02/17
14:45
02/17/18
14:45
Conference/Events
Potlatch to host special shareholder meeting »

Special Shareholder…

DEL

Deltic Timber

$98.45

1.77 (1.83%)

PCH

Potlatch

$54.75

0.75 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

PCH

Potlatch

$54.75

0.75 (1.39%)

, DEL

Deltic Timber

$98.45

1.77 (1.83%)

14:42
02/17/18
02/17
14:42
02/17/18
14:42
Conference/Events
Deltic Timber to host special shareholder meeting »

Special shareholder…

PCH

Potlatch

$54.75

0.75 (1.39%)

DEL

Deltic Timber

$98.45

1.77 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$20.42

0.67 (3.39%)

09:31
02/17/18
02/17
09:31
02/17/18
09:31
Periodicals
Snap CEO sold $50M in stock this week, Recode reports »

Snap CEO Evan Spiegel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 07

    Mar

GLPG

Galapagos NV

$115.33

-1.4 (-1.20%)

, MPSYY

MorphoSys

$46.29

1.29 (2.87%)

09:27
02/17/18
02/17
09:27
02/17/18
09:27
Hot Stocks
Galapagos NV, MorphoSys present results from Phase 1 study with MOR106 in AD »

Galapagos NV (GLPG) and…

GLPG

Galapagos NV

$115.33

-1.4 (-1.20%)

MPSYY

MorphoSys

$46.29

1.29 (2.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$360.53

-0.47 (-0.13%)

09:22
02/17/18
02/17
09:22
02/17/18
09:22
Hot Stocks
Lockheed Martin receives Freedom-variant FFG conceptual design contract »

The U.S. Navy awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

  • 30

    May

UAA

Under Armour; also tag UA

$17.36

-1.05 (-5.70%)

, UA

Under Armour; also tag UAA

$15.78

-0.76 (-4.59%)

09:11
02/17/18
02/17
09:11
02/17/18
09:11
Periodicals
Bears, bulls battle over Under Armour, Barron's says »

In a follow-up story,…

UAA

Under Armour; also tag UA

$17.36

-1.05 (-5.70%)

UA

Under Armour; also tag UAA

$15.78

-0.76 (-4.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOV

Hovnanian

$2.24

0.12 (5.66%)

09:04
02/17/18
02/17
09:04
02/17/18
09:04
Periodicals
Hovnanian stock too cheap to ignore, Barron's says »

Hovnanian Enterprises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

, JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

09:00
02/17/18
02/17
09:00
02/17/18
09:00
Periodicals
JPMorgan, Walmart cash flow yields exceed dividend yields, Barron's says »

The cash flow yields of…

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

WMT

Walmart

$104.78

1.55 (1.50%)

PFE

Pfizer

$36.26

0.55 (1.54%)

CSCO

Cisco

$44.33

0.25 (0.57%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

PEP

PepsiCo

$111.06

0.09 (0.08%)

MMM

3M

$236.67

1.8 (0.77%)

BMY

Bristol-Myers

$68.96

-0.02 (-0.03%)

UTX

United Technologies

$129.26

-0.74 (-0.57%)

TXN

Texas Instruments

$104.47

-0.1 (-0.10%)

ABT

Abbott

$60.17

0.67 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 13

    Mar

  • 29

    Mar

  • 04

    Apr

  • 13

    Apr

  • 30

    May

  • 14

    Jul

  • 12

    Oct

GOOGL

Alphabet Class A

$1,095.50

4.14 (0.38%)

, GOOG

Alphabet

$1,094.80

5.28 (0.48%)

08:56
02/17/18
02/17
08:56
02/17/18
08:56
Periodicals
Alphabet, Citi well positioned for later stages of market rally, Barron's says »

It is time for investors…

GOOGL

Alphabet Class A

$1,095.50

4.14 (0.38%)

GOOG

Alphabet

$1,094.80

5.28 (0.48%)

C

Citi

$76.82

-0.26 (-0.34%)

CMI

Cummins

$165.60

0.58 (0.35%)

LRCX

Lam Research

$187.91

2.2 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 18

    Mar

  • 28

    Mar

  • 29

    Mar

  • 30

    May

GE

General Electric

$15.05

0.2 (1.35%)

08:48
02/17/18
02/17
08:48
02/17/18
08:48
Periodicals
General Electric stock could drop another 10%, Barron's says »

General Electric lost $6B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$63.19

-0.52 (-0.82%)

, VMC

Vulcan Materials

$126.57

-6.9 (-5.17%)

08:32
02/17/18
02/17
08:32
02/17/18
08:32
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

JEC

Jacobs Engineering

$63.19

-0.52 (-0.82%)

VMC

Vulcan Materials

$126.57

-6.9 (-5.17%)

PWR

Quanta Services

$35.07

0.24 (0.69%)

EXP

Eagle Materials

$102.75

-3.83 (-3.59%)

FLR

Fluor

$57.63

-0.22 (-0.38%)

USCR

U.S. Concrete

$78.00

-1.4 (-1.76%)

ACM

Aecom

$35.36

0.08 (0.23%)

CBI

CB&I

$18.71

0.04 (0.21%)

GVA

Granite Construction

$60.36

2.69 (4.66%)

CAT

Caterpillar

$156.29

-3.69 (-2.31%)

MLM

Martin Marietta

$216.25

-6.34 (-2.85%)

V

Visa

$121.85

-0.43 (-0.35%)

AA

Alcoa

$47.36

-0.21 (-0.44%)

ARNC

Arconic

$25.36

0.14 (0.56%)

CENX

Century Aluminum

$24.12

1.85 (8.31%)

X

U.S. Steel

$44.75

5.76 (14.77%)

STLD

Steel Dynamics

$49.40

2.26 (4.79%)

AKS

AK Steel

$5.96

0.72 (13.74%)

CLF

Cleveland-Cliffs

$7.92

0.55 (7.46%)

NUE

Nucor

$68.54

2.96 (4.51%)

MT

ArcelorMittal

$36.48

1.19 (3.37%)

TKR

Timken

$45.00

-0.08 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 01

    Mar

  • 14

    Mar

  • 23

    May

  • 30

    May

04:55
02/17/18
02/17
04:55
02/17/18
04:55
Conference/Events
Cambridge Healthtech Institute to hold a conference »

Molecular Med Tri-Con…

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

, ABBV

AbbVie

$118.60

3.7 (3.22%)

04:55
02/17/18
02/17
04:55
02/17/18
04:55
Conference/Events
American Academy of Dermatology holds annual meeting »

2018 AAD Annual Meeting…

ACRS

Aclaris Therapeutics

$20.13

-0.09 (-0.45%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

AGN

Allergan

$164.04

-0.43 (-0.26%)

ALIOF

Actelion

ARDX

Ardelyx

$5.80

-0.2 (-3.33%)

BVX

Bovie Medical

$2.50

0.1 (4.17%)

CELG

Celgene

$95.26

-0.88 (-0.92%)

CUTR

Cutera

$48.40

-2.1 (-4.16%)

HSIC

Henry Schein

$69.52

1.14 (1.67%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

LLY

Eli Lilly

$78.97

0.95 (1.22%)

LMNS

Lumenis

MYGN

Myriad Genetics

$32.81

-0.57 (-1.71%)

MYL

Mylan

$42.14

0.49 (1.18%)

NVS

Novartis

$86.91

0.23 (0.27%)

PFE

Pfizer

$36.26

0.55 (1.54%)

PG

Procter & Gamble

$82.60

0.19 (0.23%)

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

REGN

Regeneron

$332.15

-1.03 (-0.31%)

SNY

Sanofi

$39.91

0.19 (0.48%)

UL

Unilever; also tag UN

$53.55

-0.22 (-0.41%)

UN

Unilever; also tag UL

$54.59

-0.15 (-0.27%)

WTKWY

Wolters Kluwer

$49.37

-0.27 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 26

    Feb

  • 27

    Feb

  • 02

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 12

    Mar

  • 12

    Mar

  • 25

    Mar

  • 29

    Mar

  • 04

    Apr

  • 23

    Apr

  • 02

    May

  • 03

    May

  • 17

    May

  • 30

    May

  • 13

    Nov

MIDD

Middleby

$135.00

1.94 (1.46%)

18:01
02/16/18
02/16
18:01
02/16/18
18:01
Hot Stocks
Middleby acquires Hinds-Bock Corporation, terms not disclosed »

Middleby announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.14

0.14 (0.38%)

, TWX

Time Warner

$95.37

0.38 (0.40%)

17:37
02/16/18
02/16
17:37
02/16/18
17:37
Periodicals
Breaking Periodicals news story on AT&T, Time Warner »

Judge says to rule on …

T

AT&T

$37.14

0.14 (0.38%)

TWX

Time Warner

$95.37

0.38 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

CARS

Cars.com

$29.27

0.33 (1.14%)

17:31
02/16/18
02/16
17:31
02/16/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Cars.com »

Starboard raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONTX

Onconova

$1.07

0.01 (0.94%)

17:29
02/16/18
02/16
17:29
02/16/18
17:29
Hot Stocks
683 Capital reports 21.8% stake in Onconova, says shares undervalued »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$224.19

-1.21 (-0.54%)

17:26
02/16/18
02/16
17:26
02/16/18
17:26
Hot Stocks
General Dynamics awarded $148.9M government contract modification »

General Dynamics Land…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRS

Antares Pharma

$2.39

0.04 (1.70%)

17:25
02/16/18
02/16
17:25
02/16/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Antares Pharma »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$265.70

10.31 (4.04%)

17:25
02/16/18
02/16
17:25
02/16/18
17:25
Hot Stocks
Huntington Ingalls awarded $1.43B government contract modification »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DIT

AMCON Distributing

$87.50

0.13 (0.15%)

17:24
02/16/18
02/16
17:24
02/16/18
17:24
Hot Stocks
Breaking Hot Stocks news story on AMCON Distributing »

Hale Partnership reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$41.09

-0.76 (-1.82%)

, TSLA

Tesla

$335.49

1.425 (0.43%)

17:11
02/16/18
02/16
17:11
02/16/18
17:11
Periodicals
Chevy Bolt sales bolstered by Tesla delays, tax credit worries, Reuters says »

Certain potential buyers…

GM

General Motors

$41.09

-0.76 (-1.82%)

TSLA

Tesla

$335.49

1.425 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

AGN

Allergan

$164.04

-0.43 (-0.26%)

17:11
02/16/18
02/16
17:11
02/16/18
17:11
Syndicate
Breaking Syndicate news story on Allergan »

Allergan files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 25

    Mar

MOG

Moog Inc

17:10
02/16/18
02/16
17:10
02/16/18
17:10
Hot Stocks
Moog in agreement to acquire VUES for $65M in cash »

Moog announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$33.93

-0.09 (-0.26%)

17:03
02/16/18
02/16
17:03
02/16/18
17:03
Hot Stocks
FDA expands approval of AstraZeneca's Imfinzi in NSLC treatment »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 23

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.